For research use only. Not for therapeutic Use.
Procaterol Hydrochloride is a specific and very potent β2-AR agonist. It acts as a vasodialator for long term treatment of asthma.
Catalog Number | I008879 |
CAS Number | 62929-91-3 |
Synonyms | Procaterol Hydrochloride; C16H22N2O3.HCl; Procaterolhydrochloridehemidrate; OPC 2009; EINECS 263-763-0; CI 888; CI-888; CI888; Hydrochloride, Procaterol; Procaterol Monohydrochloride, (R*,R*)-(+)-Isomer; Procaterol Monohydrochloride, (R*,R*)-(+-)-Iso |
Molecular Formula | C16H22N2O3.HCl |
Purity | ≥95% |
Target | Adrenergic Receptor |
Solubility | Soluble in DMSO, not in water |
Storage | Store at RT |
Reference | </br>1:Exploring the electrochemiluminescent behavior of procaterol hydrochloride in the presence of Ru(bpy)<sub>3</sub><sup>2+</sup> and its analytical application in pharmaceutical preparation. Kong D, Hu F, Jiang L, Lin J, Wei Q, Chi Y, Chen G.Luminescence. 2016 Nov 15. doi: 10.1002/bio.3245. [Epub ahead of print] PMID: 27862870 </br>2:Pulmonary liposomal formulations encapsulated procaterol hydrochloride by a remote loading method achieve sustained release and extended pharmacological effects. Tahara K, Tomida H, Ito Y, Tachikawa S, Onodera R, Tanaka H, Tozuka Y, Takeuchi H.Int J Pharm. 2016 May 30;505(1-2):139-46. doi: 10.1016/j.ijpharm.2016.03.031. Epub 2016 Mar 21. PMID: 27012982 </br>3:Design of highly sensitive phosphorescence sensor for determination of procaterol hydrochloride based on inhibition of KClO3 oxidation fluorescein isothiocyanate. Liu JM, Huang Q, Liu ZB, Zhang LH, Zheng ZY, Lin CQ.Luminescence. 2015 Jun;30(4):382-7. doi: 10.1002/bio.2743. Epub 2014 Jul 18. PMID: 25044504 </br>4:Pharmacokinetic study of the oral administration of procaterol hydrochloride hydrate 50 µg in healthy adult Japanese men. Kobayashi H, Masuda M, Kashiyama E, Koga N, Yasuda Y, Shibutani T, Endo K, Funaki T, Miyamoto T.Int J Clin Pharmacol Ther. 2010 Nov;48(11):744-50. PMID: 20979933 </br>5:[Flow-injection chemiluminescence determination of procaterol hydrochloride]. Rao ZM, Zou P, Chen M, Xiu FR, Chen YL, Hong KJ.Guang Pu Xue Yu Guang Pu Fen Xi. 2008 Feb;28(2):269-72. Chinese. PMID: 18479001 </br>6:[Bronchial asthma attack with lactic acidosis and hypokalemia in a case receiving high dose inhalation of procaterol hydrochloride]. Noma S, Kubota S, Matsukizono K, Tanoue A, Kumamoto T, Taira T, Mitsuyama H, Kawabata T, Suetsugu T, Iwakaw J, Koreed Y, Matsuyama W, Mizuno K, Higashimoto I, Osame M, Arimura K.Nihon Kokyuki Gakkai Zasshi. 2007 Apr;45(4):361-5. Japanese. PMID: 17491317 </br>7:Pharmacodynamic equivalence study of CFC-free and CFC-containing procaterol hydrochloride metered-dose inhalers. Kawai M, Nakashima M, Takaori S, Nakamura Y, Akamatsu K, Nakashima M, Miyamoto T.Methods Find Exp Clin Pharmacol. 2005 Oct;27(8):555-8. PMID: 16273135 </br>8:Pharmacodynamic study of procaterol hydrochloride dry powder inhaler: evaluation of pharmacodynamic equivalence between procaterol hydrochloride dry powder inhaler and procaterol hydrochloride metered-dose inhaler in asthma patients in a randomized, double-dummy, double-blind crossover manner. Kawai M, Sakai A, Takaori S, Hiura A, Sakata N, Nakashima M, Miyamoto T.Methods Find Exp Clin Pharmacol. 2005 Jul-Aug;27(6):385-9. PMID: 16179955 </br>9:Large and small airway responses to procaterol hydrochloride administered through different extension devices in asthmatic patients. Fontana GA, Lavorini F, Chiostri M, Castellani W, Boddi V, Pistolesi M.J Aerosol Med. 1999 Fall;12(3):177-85. PMID: 10623334 </br>10:[Oleic acid-induced PaO2 decrease model for primary screening of drugs for hypoxemia: effects of tranexamic acid and procaterol hydrochloride on the decrease in PaO2]. Moriuchi H, Yuizono T.Nihon Yakurigaku Zasshi. 1994 Jan;103(1):27-36. Japanese. PMID: 8314181 |